Teacher Retirement System of Texas’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.46M Sell
18,125
-705
-4% -$213K 0.01% 511
2026
Q1
$6.23M Sell
18,830
-1,205
-6% -$410K 0.03% 469
2025
Q4
$7.97M Sell
20,035
-13,607
-40% -$6.02M 0.03% 402
2025
Q3
$15.3M Sell
33,642
-2,766
-8% -$1.13M 0.06% 281
2025
Q2
$11.9M Buy
36,408
+1,123
+3% +$311K 0.05% 325
2025
Q1
$9.53M Sell
35,285
-3,790
-10% -$974K 0.04% 349
2024
Q4
$9.2M Buy
39,075
+5,425
+16% +$1.43M 0.03% 352
2024
Q3
$9.26M Buy
33,650
+4,285
+15% +$1.12M 0.04% 333
2024
Q2
$7.14M Buy
29,365
+832
+3% +$131K 0.04% 333
2024
Q1
$4.26M Sell
28,533
-681
-2% -$114K 0.03% 435
2023
Q4
$5.59M Sell
29,214
-3,744
-11% -$638K 0.04% 375
2023
Q3
$5.84M Buy
32,958
+692
+2% +$132K 0.04% 379
2023
Q2
$6.13M Buy
32,266
+3,479
+12% +$690K 0.04% 375
2023
Q1
$5.77M Buy
28,787
+15,422
+115% +$3.24M 0.04% 433
2022
Q4
$3.18M Sell
13,365
-4,009
-23% -$855K 0.02% 530
2022
Q3
$3.48M Sell
17,374
-1,054
-6% -$201K 0.03% 498
2022
Q2
$2.69M Sell
18,428
-6,115
-25% -$868K 0.02% 536
2022
Q1
$4.01M Buy
24,543
+1,905
+8% +$290K 0.02% 541
2021
Q4
$3.84M Sell
22,638
-6,797
-23% -$1.26M 0.02% 578
2021
Q3
$5.56M Buy
29,435
+14,319
+95% +$2.69M 0.03% 475
2021
Q2
$2.56M Buy
15,116
+2,275
+18% +$333K 0.01% 650
2021
Q1
$1.81M Buy
12,841
+2,380
+23% +$358K 0.01% 693
2020
Q4
$1.36M Sell
10,461
-18,218
-64% -$2.43M 0.01% 688
2020
Q3
$4.18M Sell
28,679
-18,139
-39% -$2.58M 0.03% 469
2020
Q2
$6.93M Buy
+46,818
New +$6.31M 0.06% 344
2019
Q4
Sell
-13,049
Closed -$1.05M 579
2019
Q3
$1.05M Sell
13,049
-2,573
-16% -$204K 0.01% 513
2019
Q2
$1.13M Buy
15,622
+3,727
+31% +$286K 0.01% 490
2019
Q1
$1.11M Sell
11,895
-1,089
-8% -$91.1K 0.01% 474
2018
Q4
$947K Sell
12,984
-6,813
-34% -$524K 0.01% 456
2018
Q3
$1.73M Sell
19,797
-4,296
-18% -$432K 0.01% 543
2018
Q2
$2.37M Buy
24,093
+4,578
+23% +$454K 0.02% 555
2018
Q1
$2.32M Sell
19,515
-4,535
-19% -$585K 0.02% 567
2017
Q4
$3.06M Buy
24,050
+17,302
+256% +$2.17M 0.02% 555
2017
Q3
$793K Buy
6,748
+267
+4% +$22.8K ﹤0.01% 572
2017
Q2
$517K Buy
6,481
+538
+9% +$34.4K ﹤0.01% 533
2017
Q1
$305K Sell
5,943
-296
-5% -$13.7K ﹤0.01% 709
2016
Q4
$234K Buy
6,239
+3,199
+105% +$134K ﹤0.01% 853
2016
Q3
$206K Sell
3,040
-2,404
-44% -$170K ﹤0.01% 1281
2016
Q2
$302K Buy
5,444
+1,291
+31% +$81.3K ﹤0.01% 1154
2016
Q1
$261K Buy
4,153
+2,296
+124% +$153K ﹤0.01% 1167
2015
Q4
$175K Sell
1,857
-2,204
-54% -$204K ﹤0.01% 1215
2015
Q3
$326K Buy
4,061
+1,161
+40% +$129K ﹤0.01% 1008
2015
Q2
$348K Buy
2,900
+643
+28% +$76.8K ﹤0.01% 650
2015
Q1
$236K Buy
2,257
+291
+15% +$29.5K ﹤0.01% 833
2014
Q4
$191K Buy
1,966
+63
+3% +$5.84K ﹤0.01% 689
2014
Q3
$149K Sell
1,903
-133
-7% -$8.58K ﹤0.01% 690
2014
Q2
$129K Sell
2,036
-163
-7% -$9.69K ﹤0.01% 836
2014
Q1
$148K Buy
2,199
+84
+4% +$6.5K ﹤0.01% 624
2013
Q4
$136K Sell
2,115
-4,935
-70% -$294K ﹤0.01% 654
2013
Q3
$451K Buy
7,050
+3,258
+86% +$162K ﹤0.01% 668
2013
Q2
$118K Buy
+3,792
New +$101K ﹤0.01% 1085

Other funds holding ALNY

Teacher Retirement System of Texas's ALNY Position: Q2 2026 in Review

Teacher Retirement System of Texas reduced its Alnylam Pharmaceuticals (ALNY) stake by 3.7% in Q2 2026, selling an estimated $213K and leaving 18,125 shares worth $5.46M. The position accounts for 0.01% of the portfolio, ranked #511.

Teacher Retirement System of Texas first reported a position in ALNY in Q2 2013 and has held it in 51 quarters since. The position peaked at $15.3M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Teacher Retirement System of Texas held 18,125 shares of Alnylam Pharmaceuticals worth $5.46M as of Q2 2026.
  • Teacher Retirement System of Texas sold 705 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $213K.
  • Alnylam Pharmaceuticals made up 0.01% of Teacher Retirement System of Texas's portfolio in Q2 2026, its #511 holding.
  • Teacher Retirement System of Texas first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Teacher Retirement System of Texas's Alnylam Pharmaceuticals position peaked at $15.3M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Teacher Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.